diabetes

Is Merck & Co., Inc Januvia In Trouble? FDA Panel Decides Tomorrow
Bidness, ETC
Mon, 06/27/16 - 03:13 pm
Merck
Januvia
diabetes
FDA
advisory panels
Jardiance
Eli Lilly
MannKind - Afrezza Scripts Still Slipping Ahead Of Re-Launch
Seeking Alpha
Sat, 06/25/16 - 01:37 pm
MannKind
Sanofi
Afrezza
diabetes
inhaled insulin
MannKind Will Market Afrezza Better Than Sanofi Ever Did
Forbes
Fri, 06/24/16 - 04:07 pm
MannKind
Afrezza
Sanofi
inhaled insulin
diabetes
FDA panel to vote whether diabetes drug cuts cardiac death
Yahoo/Reuters
Fri, 06/24/16 - 04:06 pm
FDA
advisory panels
diabetes
Eli Lilly
Boehringer Ingelheim
Jardiance
Eli Lilly Shows Terrific Innovation
Seeking Alpha
Thu, 06/23/16 - 09:18 am
Eli Lilly
Jardiance
olaratumab
abemaciclib
innovation
diabetes
cancer
How Big Is the Diabetes Treatment Market?
Motley Fool
Wed, 06/22/16 - 07:06 pm
diabetes
Eli Lilly
Novo Nordisk
Lilly execs: Net price pressures not a concern for new diabetes meds
Fierce Pharma
Tue, 06/21/16 - 11:28 am
Eli Lilly
diabetes
drug pricing
Mannkind Afrezza Launch 2.0: How It Is Different This Time Around
Seeking Alpha
Mon, 06/20/16 - 09:48 pm
MannKind
Afrezza
diabetes
inhaled insulin
drug launches
What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?
Motley Fool
Mon, 06/20/16 - 10:27 am
Novo Nordisk
diabetes
Victoza
MannKind - Managing Expectations Of An Afrezza Relaunch
Seeking Alpha
Fri, 06/17/16 - 09:36 pm
MannKind
Afrezza
diabetes
inhaled insulin
Why This Pharma Giant Lost $8 Billion in Market Cap This Week
Fortune
Fri, 06/17/16 - 10:25 am
Novo Nordisk
Victoza
diabetes
Merck, Pfizer expand trial studying CV benefit of experimental diabetes drug
BioPharma Dive
Wed, 06/15/16 - 11:11 pm
Merck
Pfizer
diabetes
clinical trials
ertugliflozin
Lilly and Boehringer's Jardiance sets new bar, shows kidney benefit
BioPharma Dive
Wed, 06/15/16 - 05:42 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
kidney disease
Merck eyes US approval with positive data on Lantus copy
BioPharma Dive
Tue, 06/14/16 - 09:30 pm
Merck
diabetes
Lantus
MK-1293
Sanofi
FDA warns of kidney risks for diabetes drugs from Janssen, AstraZeneca
BioPharma Dive
Tue, 06/14/16 - 07:27 pm
FDA
diabetes
Janssen
JNJ
AstraZeneca
Farxiga
Invokana
Novo Nordisk Drug Cuts Diabetic Deaths, But Not Enough For Wall Street
Investors.com
Tue, 06/14/16 - 10:04 am
Novo Nordisk
diabetes
Victoza
AZ tallies a pair of Farxiga wins with new data from renal, potassium analyses
Fierce Pharma
Mon, 06/13/16 - 07:12 pm
AstraZeneca
Farxiga
diabetes
Novo diabetes drug cuts heart risks by 13 pct in key trial
Yahoo/Reuters
Mon, 06/13/16 - 07:03 pm
Novo Nordisk
diabetes
Victoza
Zafgen up 6% after weight loss drug has positive late-stage trial results
Marketwatch
Mon, 06/13/16 - 11:28 am
Zafgen
obesity
beloranib
diabetes
Sanofi's diabetes drug hits trial targets, heads for final approval
BioPharma Dive
Mon, 06/13/16 - 11:27 am
Sanofi
diabetes
LixiLan
FDA

Pages